Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glycemic Variability of Combination Therapies in T2DM — Stella

Home/Type 2 Diabetes Mellitus (T2DM)/Glycemic Variability of Combination Therapies in T2DM

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes Mellitus (T2DM) trials

Glycemic Variability of Combination Therapies in T2DM

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

South Korea

The Catholic University of Korea, Bucheon St. Mary's Hospital, Principal Investigator, Seoul

Key details

Phase

Post-approval study

Sponsor

JW Pharmaceutical

Enrollment target

~178 participants

Started

October 2025

Primary completion

March 2027

Age range

19 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.